Gantenerumab Biosimilar - Research Grade,ichor.bio,ICH5009

Detects human Beta Amyloid. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Gantenerumab.

Host

CHO cells

Reactivity

Human

Platform ID

BAB698720069

ichor.bio

Headquarters

Grove Business Park Downsview Road Wantage OX12 9FF

Contact

Tel:
Fax:

Product Specifications
Scientific Background

Specifications

NameGantenerumab Biosimilar - Research Grade
Cat. No.ICH5009
Accession NumberP05067
HostCHO cells
IsotypeHuman IgG1
ReactivityHuman
Concentration5mg/ml
TargetBeta Amyloid
Purity>95% by SDS-PAGE
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3002
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only

Scientific Background

RUO gantenerumab is a monoclonal antibody for the treatment of Alzheimerï؟½s disease being developed by Hoffmann-La Roche pharmaceuticals. Gantenerumab binds to and clears aggregated beta amyloid fibers. A phase III clinical trial of gantenerumab was stop

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.